French Drugmaker Sparks Outrage In France By Asserting U.S. Would Receive Covid-19 Vaccine FirstForbes • 05/14/20
Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes U.S. preordersReuters • 05/13/20
Here's Why Investors Should Follow Sanofi and GlaxoSmithKline's New Coronavirus CollaborationThe Motley Fool • 04/30/20
Positive Cancer Trial Results Offset a COVID-19 Flop for Regeneron and SanofiThe Motley Fool • 04/27/20
Regeneron and Sanofi’s arthritis drug shows no benefit in non-critical COVID-19 patientsInvezz • 04/27/20
Regeneron, Sanofi Say Kevzara Will Now Only Be Tested in Sickest COVID-19 PatientsThe Motley Fool • 04/27/20
Regeneron, Sanofi say Kevzara will only be tested in sickest COVID-19 patientsMarket Watch • 04/27/20
Regeneron, Sanofi arthritis drug shows benefit for sickest coronavirus patients, but not for less- advanced casesCNBC • 04/27/20